Skip to main content
. 2018 Jan 31;131(16):1805–1808. doi: 10.1182/blood-2017-08-802561

Table 2.

FDG-PET response

FDG-PET response, n = 20 evaluable CR (%) PR (%) ORR, %
COO/subtype
 GC, n = 3 1 (33) 0 (0) 33
 Non-GC, n = 8 8 (100)* 0 (0) 100
 PMBL, n = 4 0 (0) 4 (100) 100
 Richter, n = 5 2 (40) 3 (60) 100
Overall, n = 20 11 (55) 7 (35) 90

In univariate analysis, non-GC patients had a significantly increased rate of metabolic CR compared with other phenotypes (P = .008).